Goldman Sachs’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-16,776
Closed -$8K 7468
2016
Q2
$8K Buy
+16,776
New +$26.9K ﹤0.01% 6895
2016
Q1
Sell
-16,006
Closed -$49K 7696
2015
Q4
$49K Buy
16,006
+4,342
+37% +$19.6K ﹤0.01% 6559
2015
Q3
$52K Buy
+11,664
New +$68.5K ﹤0.01% 6783
2015
Q2
Sell
-32,046
Closed -$287K 7721
2015
Q1
$287K Buy
32,046
+21,450
+202% +$172K ﹤0.01% 5693
2014
Q4
$60K Buy
+10,596
New +$55.4K ﹤0.01% 6758

Other funds holding EPRS